Blog

Phoenix UGM 2024: A day of innovation and collaboration

The Phoenix UGM featured industry expert insights, peer networking, and glimpses into the latest PK/PD…

CertaraMay 31, 2024

On-Demand Webinar

What is new in Phoenix 8.5?

Discover the latest advancements and enhancements in Phoenix version 8.5. Watch the webinar to learn…

CertaraFebruary 26, 2024

Publication

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…

CertaraFebruary 23, 2024

On-Demand Webinar

Streamlining Your NCA Workflow

PK analysis intended for submission contends with many data and compliance challenges. To work efficiently,…

CertaraJanuary 18, 2024

Publication

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…

CertaraJune 28, 2023

Case Study

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

CertaraJune 1, 2023

Conference

American College of Toxicology 2026 Annual Meeting

– – Booth

Kevin Snyder, PhDMay 24, 2023

Conference

ACoP 2026

CertaraMay 24, 2023

Publication

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Explore how tumor growth inhibition modeling can support go/no-go decisions in early Phase Ib/II oncology…

CertaraMarch 24, 2023

Blog

Tips & tricks for optimizing your pharmacokinetic modeling & simulation

Learn how to streamline your PK/PD workflows with expert tips.

CertaraMarch 23, 2023

Modeling and Simulation – PK/PD

Phoenix UGM 2024: A day of innovation and collaboration

What is new in Phoenix 8.5?

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

Streamlining Your NCA Workflow

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

American College of Toxicology 2026 Annual Meeting

ACoP 2026

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Tips & tricks for optimizing your pharmacokinetic modeling & simulation

Newsletter sign up

Quick links

Solutions

Contact